ReviewJournal of Cancer2026

Overcoming Resistance to PARP Inhibitors in BRCA-Mutated Cancers: Mechanisms and Therapeutic Strategies.

Jiahui Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.